Cellix Biosciences
Newark, US · Founded 2017 · Delaware corporation
Founders & leadership
MK
Mahesh KandulaNamed on SEC filing
SA
Subramaniam ApparsundaramNamed on SEC filing
JK
Jaideep KhannaNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 1 round · 2019
▶$1.5MraisedMar 2021 · 8 investors · OtherRule 506(b)
▶$1.5MraisedMar 2021 · 8 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Mahesh KandulaDirector
- Subramaniam ApparsundaramExecutive Officer, Director, Promoter
- Jaideep KhannaDirector
- Offering amount
- $3M
- Amount sold
- $1.5M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cellix Biosciences raised?
- Cellix Biosciences has disclosed $1.5M raised across 1 round.
- Where is Cellix Biosciences headquartered?
- Cellix Biosciences is headquartered in Newark, US.